Ascendis Pharma A/S logo

Ascendis Pharma A/S

ASNDNASDAQ NMS - GLOBAL MARKET

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. The firm produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The firm operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).

Latest news, analyst ratings, earnings reports, dividends, insider trades, and market analysis for Ascendis Pharma A/S.

BiotechnologyHealth Care

Company Information

Employees
1,017
IPO Date
January 28, 2015

Contact Information

Address
Tuborg Boulevard 12, Hellerup DK

Market Snapshot

Last Updated: Nov 8, 2025, 3:25 PM · Source: Finnhub.io

all
52-Week High
$216.45
52-Week Low
$118.03
52-Week Return
52.9%
10-Day Avg Volume
0.3
Beta
0.45
Market Cap
$12.07B

Recent Articles for Ascendis Pharma A/S (ASND)